Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/22/2000EP0986537A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
03/22/2000EP0986530A1 Indane compounds and their pharmaceutical use
03/22/2000EP0986408A1 New medicaments based on polymers composed of methacrylamide-modified gelatin
03/22/2000EP0986403A1 Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof
03/22/2000EP0986400A1 Integrin ligand, human mindin
03/22/2000EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals
03/22/2000EP0986393A1 The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
03/22/2000EP0986392A1 Method of treating chronic progressive vascular scarring diseases
03/22/2000EP0986391A1 Oxyalkylene phosphate compounds and uses thereof
03/22/2000EP0986390A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
03/22/2000EP0986389A1 Novel process
03/22/2000EP0986388A1 Endocrine modulation with positive modulators of ampa type glutamate receptors
03/22/2000EP0986387A1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
03/22/2000EP0986386A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
03/22/2000EP0986385A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986384A1 Inhibitors of protein isoprenyl transferases
03/22/2000EP0986383A1 Method of suppressing tumor growth with combinations of isoprenoids and statins
03/22/2000EP0986382A1 Raf kinase inhibitors
03/22/2000EP0986381A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
03/22/2000EP0986379A1 Use of substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury
03/22/2000EP0986378A1 Phorbol esters as anti-neoplastic agents
03/22/2000EP0986377A1 Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
03/22/2000EP0986376A1 COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT
03/22/2000EP0986375A2 Use of mkc-442 in combination with other antiviral agents
03/22/2000EP0986372A1 Vesicular complexes and methods of making and using the same
03/22/2000EP0986314A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids
03/22/2000EP0986302A1 A method of treating cancer
03/22/2000EP0866814B1 Copolymers of olefinically unsaturated monocarboxylic acids, olefinically unsaturated dicarboxylic acids or their anhydrides or mixtures of such carboxylic acids or anhydrides and their use as thickeners and dispersants
03/22/2000EP0860170B1 Tablets based on isotope-labeled urea
03/22/2000EP0804203B1 Rectal flunisolide compositions for treating inflammatory intestinal disorders
03/22/2000EP0790997B1 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
03/22/2000EP0782442A4 A delivery system for antimethanogenic agents
03/22/2000EP0775114B1 Process for making antimicrobial compounds
03/22/2000EP0711155B1 Amino acid supplement
03/22/2000EP0675713B1 Use of prodelphinidines for treating arthrosis
03/22/2000EP0671912B1 Injectable taxane derivative based compositions
03/22/2000EP0665749B1 Composition for the treatment of parkinson's disease
03/22/2000EP0620814B1 Novel piprazine carboxamides
03/22/2000EP0506774B2 Smoking substitute
03/22/2000CN1248274A Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof
03/22/2000CN1248263A Process for preparing carboxamido-4-azasteroids
03/22/2000CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
03/22/2000CN1248261A Novel erythromycin derivatives, method of preparation and application as medicines
03/22/2000CN1248257A Compound for inhibition of gastric acid secretion
03/22/2000CN1248254A Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for treatment of neurodegenerative and CNS-trauma related conditions
03/22/2000CN1248253A Tricyclic compounds useful for inhibition of farnesyl protein transferase
03/22/2000CN1248251A Disubstituted bicyclic heterocycles, their production and use as medicaments
03/22/2000CN1248249A 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
03/22/2000CN1248248A Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as AMPA-receptor antagonists
03/22/2000CN1248246A 4-aminoethoxyindazole derivatives
03/22/2000CN1248243A Compounds
03/22/2000CN1248177A Coated particles, method of making and using
03/22/2000CN1248170A Preparation for treatment of metabolic syndrome containing human growth hormone in combination with cortisol synthesis inhibitor
03/22/2000CN1248169A Compositions for treatment of ARDS or IRDS containing 3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamide and lung surfactant
03/22/2000CN1248168A Use of 9,10-secocholesta-5,7,10 (19)-triene-1,3-diol, or alfacacidol
03/22/2000CN1248167A Administration of injectable antibiotic in ear of animal
03/22/2000CN1248166A Anticancer composition
03/22/2000CN1248165A Nimesulide gel system for topical use
03/22/2000CN1248164A Antiviral agents
03/22/2000CN1248163A Pharmaceutical preparation comprising lyophilized lipsomes encapsulating active principle which is highly insoluble in water, and the process for preparing the said preparation
03/22/2000CN1248162A Topical pharmaceutical composition comprising cholinergic agent or calcium channel blocker
03/22/2000CN1248158A Method for improving health of hair and scalp
03/22/2000CN1248155A Compositions to control oral microbial oxidation-reduction (Eh) levels
03/22/2000CN1247865A Prepn. of quinolone and 1,8-diaza-naphthalenone carboxylic acid
03/22/2000CN1247855A Preparation and application of tanshinpolyphenolic salt
03/22/2000CN1247754A Medicine ointment for skin allergy caused by violet ray and cosmetics, dermatitis and other skin diseases
03/22/2000CN1247753A Toothache pill (powder)
03/22/2000CN1247751A Chinese medicine for treating calculus hydrops of liver, gall and kidney
03/22/2000CN1247741A Emulsified inhalational anaesthetic for intravenous injection and its preparation
03/22/2000CN1050605C Cycloalkano-indole and -azaindole derivatives, its prepn. and medical composition containing them
03/22/2000CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides
03/22/2000CN1050601C Novel aminoalkyl benzothiazolinone, its prepn. and medical composition containing the compound
03/22/2000CN1050514C Antiallergic composition for ophthalmic or nasal use
03/21/2000US6040451 Used as analgesic, sedative and anaesthetic agents
03/21/2000US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base
03/21/2000US6040444 Process for preparing furan nitrone compounds
03/21/2000US6040442 Process for preparing 1,2,5-thiadiazole containing ethers
03/21/2000US6040435 Antimicrobial cationic peptides
03/21/2000US6040434 Screening for compound which reduces or prevents formation of 3'-amino-3'-deoxythymidine from 3'-azido-3'-deoxythymidine (azt); side effect reduction in mammals receiving viricidal therapy
03/21/2000US6040432 Metal complexes, of DTPA derivatives suitable for use in diagnosis and therapy
03/21/2000US6040431 Single chain analogs of the TGF-β superfamily (morphons)
03/21/2000US6040347 Treatment of seborrhoea/cutaneous disorders with octoxyglycerol
03/21/2000US6040346 Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
03/21/2000US6040344 Crystalline r,r-formoterol l-(+)-tartrate.
03/21/2000US6040343 Remedy for keratoconjunctival diseases
03/21/2000US6040342 Retinoyloxy (alkyl-substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
03/21/2000US6040341 Compounds and their compositions having anti-inflammatory and anti-thrombotic activities
03/21/2000US6040340 Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
03/21/2000US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal
03/21/2000US6040338 N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents
03/21/2000US6040337 5-demethoxyfumagillol derivatives and processes for preparing the same
03/21/2000US6040336 Treating bacterially induced meningitis
03/21/2000US6040334 Lovastatin and derivatives
03/21/2000US6040332 Inhibit glucosyl ceramide (glccer) formation by inhibiting the enzyme glccer synthase, thereby lowering the level of glycosphingolipids.
03/21/2000US6040330 Pharmaceutical formulations of taxanes
03/21/2000US6040329 Substituted indazole analogs
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
03/21/2000US6040327 Benzimidazole, benzoxazole and benzothiazole compounds
03/21/2000US6040326 3-deoxyglucosone production inhibitor
03/21/2000US6040324 Prophylactic or therapeutic drug for renal diseases